Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Wiley eBooks

Quantum‐Enabled Drug Discovery Process

Abhishek Rao, Deepika Kumari, Satyendra Singh, Ketan Kumar, Vijay Kumar Prajapati

Published Jul 1, 2024• 3 citations
Publisher

Abstract

Quantum computational tools and their application in the field of drug discovery and design are new and advanced implementation of computer science. Old computational techniques are need to be improved to perform the task in less time and with precise accuracy on the lowest scale. A quantum computer uses a fundamentally advanced computational process to detect molecules and entities at the quantum level. Quantum computer applications are exact and accurate about their detection so that they can analyze minute differences and changes that classical computers cannot. Drug designing and discovery involves advanced application methods like the Fragment Molecular Orbital (FMO) method with the analysis of each fragment and all of the components, including bond energies, orientation, ligation energies, π–π stacking, halogen–π, halogen bonds, cation–π, hydrophobic interactions, and non-classical hydrogen bonds. The interacting molecular structure has different characteristic properties such as self-diffusion constant, root mean square displacement of atomic coordinates from beginning coordinates, radius of gyration, radial density profile (only for spherical boundary conditions), dielectric constant, and radial distribution function, which are some of the parametrical attributes that can be implemented for precise verification. Such characteristics can be sorted and are detected by specific quantum applications like MM and QM/MM (quantum mechanics/molecular mechanics) molecular dynamics-based free energy perturbation (FEP), QuanPol, QuanPol Vibrational Spectrum Program (QPVIB), Geometry optimization, CHARMM, AMBER or QM/MM/continuum solvent MD simulations. All of these, and many other quantum computing applications, can be used as a mainstay for drug design and discovery.

DOI
10.1002/9781394159338.ch2

Related papers

Quantum Computing in Pharmaceutical Science

Bancha Yingngam

In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.

Advances in computer and electrical engineering book series•Jan 31, 2024•3 citations

Quantum computing applications in drug discovery: Unraveling complex molecular interactions

Anagha Deepak Kulkarni, Tejasvini Rahul Katkar, Smita Jadhav +1 more

This study identifies that new drugs are inherently complicated and require a lot of resources. These initiatives require years of financial investment, and the highly potent medicines that are produced were the final consequence. This study explores the potential uses of quantum computing to enhance molecular simulations and optimize drug prospect interactions. A comparative analysis between quantum and classical methodologies can be used to make a quantitative comparison. The results showed that VQE performs 37.8% more accurately than its classical predecessors, with a mean absolute error of 0.028 Hartree. Furthermore, the 86.7% success rate of QAOA in improving molecular structures would signify a significant performance improvement compared to traditional optimization methods. For VQE on quantum simulators, the average computing time is 8.4 minutes per molecule, which is 42.9% faster than for classical methods. Based on their better computational efficiency and ability to improve the accuracy of molecular property predictions, quantum algorithms appear to be a very promising tool for speeding up the drug discovery process. The results show that quantum machine learning has the potential to transform pharmaceutical research by advancing the development of new treatments.

AIP conference proceedings•Jan 1, 2026•0 citations

Quantum Computing in Drug Discovery: A Review of Foundations and Emerging Applications

Sandeep Kulkarni, Dr. Pushpalata S. Patil, Ravindra D Patil

Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.

International Journal of Advanced Pharmaceutical Sciences and Research•Jun 27, 2025•2 citations

Quantum Computing and Its Promise in Drug Discovery

Rakhi Mishra, Prem Shankar Mishra, Rupa Mazumder +2 more

It is widely accepted that quantum computation and the science of quantum computation mechanics are excellent tools for drug design and discovery because of their high precision in estimating numerous relevant parameters. A scientist can use quantum computing to perform hundreds of millions of comparisons of complex molecules at the same time to examine matches between the molecules, and both the positive and negative effects of a new therapeutic approach can be predicted. These approaches make the most significant contribution to the development of drugs in clinical use or clinical trials. These methods emerge and develop in tandem with the experimental approaches used in drug design. Quantum Computational (QC) methods offer a highly precise description of protein–ligand interactions. This method defines nuclei and electron behavior and explains molecular interactions in terms of distribution and motion. Quantum computers have the potential to revolutionize computation by solving previously intractable problems. Quantum computers are extremely fast and efficient. They can perform calculations that would take decades or even millennia on today's supercomputers in a matter of seconds. Experts refer to this fact as quantum superiority over other traditional methods. Second, QCs can also be archetypal complicated structures that will allow researchers to understand the interaction of both small molecules and biologics before the preclinical and clinical stages of drug development. In practice, quantum computational methods will not be able to take over every task performed by classical computational methods—at least not anytime soon. However, in the future, these methods may be combined with traditional computational technologies such as machine learning (ML) and artificial intelligence (AI) to pave a new and groundbreaking path toward the goal of drug discovery and development.

Wiley eBooks•Jul 1, 2024•8 citations

A brief review on quantum computing based drug design

Poulami Das, Avishek Ray, Siddhartha Bhattacharyya +5 more

Abstract Design and development of new drug molecules are essential for the survival of human society. New drugs are designed for therapeutic purposes to combat new diseases. Besides treating new diseases, new drug development is also needed to treat pre‐existing diseases more effectively and reduce the existing drugs' side effects. The design of drugs involves several steps, from the discovery of the drug molecule to its commercialization in the market. One of the most critical steps in drug design is to find the molecular interactions between the target (infected) molecule and the drug molecule. Several complex chemical equations need to be solved to determine the molecular interactions. In the late 20th Century, the advancement of computational technologies has made the solution of chemical equations relatively easier and faster. Moreover, the design of drug molecules involves multi‐criteria optimization. Classical computational methodologies have been used for drug design since the end of the 20th Century. However, nowadays, more advanced computational methodologies are inevitable in designing drugs for new diseases and drugs with fewer side effects. In this context, the quantum computing paradigm has proved beneficial in drug design due to its advanced computational capabilities. This paper presents a state‐of‐the‐art comprehensive review of the quantum computing‐based methodologies involved in drug design. A comparative study is made about the different quantum‐aided drug design methods, stating each methodology's merits and demerits. The review work presented in this manuscript will help new researchers assess the present state‐of‐the‐art concept of quantum‐based drug design. This article is categorized under: Technologies > Structure Discovery and Clustering Technologies > Computational Intelligence Application Areas > Health Care

Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery•Jul 16, 2024•10 citations

Quantum Computing in Drug Discovery Techniques, Challenges, and Emerging Opportunities

Gomase VS, Arjun P. Ghatule, Rupali Sharma +1 more

INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.

Current Drug Discovery Technologies•Sep 1, 2025•6 citations
Quantum computational tools and their application in the field of drug discovery and design are new and advanced implementation of computer science. Old computational techniques are need to be improved to perform the task in less time and with precise accuracy on the lowest scale. A quantum computer uses a fundamentally advanced computational process to detect molecules and entities at the quantum level. Quantum computer applications are exact and accurate about their detection so that they can analyze minute differences and changes that classical computers cannot. Drug designing and discovery involves advanced application methods like the Fragment Molecular Orbital (FMO) method with the analysis of each fragment and all of the components, including bond energies, orientation, ligation energies, π–π stacking, halogen–π, halogen bonds, cation–π, hydrophobic interactions, and non-classical hydrogen bonds. The interacting molecular structure has different characteristic properties such as self-diffusion constant, root mean square displacement of atomic coordinates from beginning coordinates, radius of gyration, radial density profile (only for spherical boundary conditions), dielectric constant, and radial distribution function, which are some of the parametrical attributes that can be implemented for precise verification. Such characteristics can be sorted and are detected by specific quantum applications like MM and QM/MM (quantum mechanics/molecular mechanics) molecular dynamics-based free energy perturbation (FEP), QuanPol, QuanPol Vibrational Spectrum Program (QPVIB), Geometry optimization, CHARMM, AMBER or QM/MM/continuum solvent MD simulations. All of these, and many other quantum computing applications, can be used as a mainstay for drug design and discovery.
In the field of pharmaceutical science, there is an increasing demand for advanced computational techniques to enhance drug discovery and understand complex molecular interactions. Classical models, despite their strengths, often struggle with complex biological systems and accurate drug predictions. Quantum computing, using qubits that exist in multiple states, processes information at unparalleled speeds. This chapter sheds light on the principles of quantum computing, emphasizing algorithms specifically designed for pharmaceutical applications. These methods signal groundbreaking advancements in drug design, molecular simulation, and drug interaction predictions. Quantum computers have the potential to surpass classical computers in simulating intricate molecules, thus offering more precise drug side effect forecasts. While challenges such as noise and error rates remain, the continuous evolution of quantum technology holds significant potential for breakthroughs in drug discovery and development.
This study identifies that new drugs are inherently complicated and require a lot of resources. These initiatives require years of financial investment, and the highly potent medicines that are produced were the final consequence. This study explores the potential uses of quantum computing to enhance molecular simulations and optimize drug prospect interactions. A comparative analysis between quantum and classical methodologies can be used to make a quantitative comparison. The results showed that VQE performs 37.8% more accurately than its classical predecessors, with a mean absolute error of 0.028 Hartree. Furthermore, the 86.7% success rate of QAOA in improving molecular structures would signify a significant performance improvement compared to traditional optimization methods. For VQE on quantum simulators, the average computing time is 8.4 minutes per molecule, which is 42.9% faster than for classical methods. Based on their better computational efficiency and ability to improve the accuracy of molecular property predictions, quantum algorithms appear to be a very promising tool for speeding up the drug discovery process. The results show that quantum machine learning has the potential to transform pharmaceutical research by advancing the development of new treatments.
Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.
It is widely accepted that quantum computation and the science of quantum computation mechanics are excellent tools for drug design and discovery because of their high precision in estimating numerous relevant parameters. A scientist can use quantum computing to perform hundreds of millions of comparisons of complex molecules at the same time to examine matches between the molecules, and both the positive and negative effects of a new therapeutic approach can be predicted. These approaches make the most significant contribution to the development of drugs in clinical use or clinical trials. These methods emerge and develop in tandem with the experimental approaches used in drug design. Quantum Computational (QC) methods offer a highly precise description of protein–ligand interactions. This method defines nuclei and electron behavior and explains molecular interactions in terms of distribution and motion. Quantum computers have the potential to revolutionize computation by solving previously intractable problems. Quantum computers are extremely fast and efficient. They can perform calculations that would take decades or even millennia on today's supercomputers in a matter of seconds. Experts refer to this fact as quantum superiority over other traditional methods. Second, QCs can also be archetypal complicated structures that will allow researchers to understand the interaction of both small molecules and biologics before the preclinical and clinical stages of drug development. In practice, quantum computational methods will not be able to take over every task performed by classical computational methods—at least not anytime soon. However, in the future, these methods may be combined with traditional computational technologies such as machine learning (ML) and artificial intelligence (AI) to pave a new and groundbreaking path toward the goal of drug discovery and development.
Abstract Design and development of new drug molecules are essential for the survival of human society. New drugs are designed for therapeutic purposes to combat new diseases. Besides treating new diseases, new drug development is also needed to treat pre‐existing diseases more effectively and reduce the existing drugs' side effects. The design of drugs involves several steps, from the discovery of the drug molecule to its commercialization in the market. One of the most critical steps in drug design is to find the molecular interactions between the target (infected) molecule and the drug molecule. Several complex chemical equations need to be solved to determine the molecular interactions. In the late 20th Century, the advancement of computational technologies has made the solution of chemical equations relatively easier and faster. Moreover, the design of drug molecules involves multi‐criteria optimization. Classical computational methodologies have been used for drug design since the end of the 20th Century. However, nowadays, more advanced computational methodologies are inevitable in designing drugs for new diseases and drugs with fewer side effects. In this context, the quantum computing paradigm has proved beneficial in drug design due to its advanced computational capabilities. This paper presents a state‐of‐the‐art comprehensive review of the quantum computing‐based methodologies involved in drug design. A comparative study is made about the different quantum‐aided drug design methods, stating each methodology's merits and demerits. The review work presented in this manuscript will help new researchers assess the present state‐of‐the‐art concept of quantum‐based drug design. This article is categorized under: Technologies > Structure Discovery and Clustering Technologies > Computational Intelligence Application Areas > Health Care
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.